Paris-based WhiteLab Genomics raises €23.2 million to accelerate AI-driven genomic medicine development

What happened

WhiteLab Genomics, a Paris-based BioTech company that operates with AI to design the building blocks of genomic medicines, has closed a €23.2 million ($26 million) Series B (an early stage of company funding) funding round. The round also saw participation from new investors Yaday Health […] The post Paris-based WhiteLab Genomics raises €23.2 million to accelerate AI-driven genomic medicine development appeared first on EU-Startups .

The round also saw participation from new investors Yaday Health and Blast Club, while existing backers Omnes Capital and Debiopharm Innovation Fund also joined this round. The round was led by AVP, an independent global investment platform managing over €2.5 billion in assets. Founded in 2019 by David Del Bourgo, Lucia Cinque, and Julien Cottineau, the Y-Combinator backed WhiteLab Genomics works at the intersection of AI and biology.